Bonesupport Holding AB (publ) (BONEX.ST) Research

Bonesupport Holding AB (publ) is an orthobiologics company that specializes in the development and commercialization of injectable bioceramic bone graft substitutes. These products are utilized for treating bone voids and are available internationally, including in Europe and North America. Among its key offerings are CERAMENT Bone Void Filler, a synthetic, injectable, moldable, and drillable solution comprising hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol. Additionally, the company provides CERAMENT G, an injectable ceramic bone graft substitute infused with gentamicin, and CERAMENT V, a synthetic bone void filler containing vancomycin. Bonesupport is also advancing preclinical product candidates focused on promoting bone regrowth. These future solutions are being developed for applications such as trauma, revision arthroplasty, chronic osteomyelitis, oncology, and bone and foot infections related to diabetes. Founded in 1999, the company maintains its headquarters in Lund, Sweden.

Market snapshot

Symbol
BONEX.ST
Price
$210.6
Day change
+1.15%
Market cap
$13.9B
P/E ratio
74.95x
52-week range
165-346.4
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 24 days

Peer companies

  • AddLife AB (publ) (ALIF-B.ST)
  • Ambea AB (publ) (AMBEA.ST)
  • Arjo AB (publ) (ARJO-B.ST)
  • Attendo AB (publ) (ATT.ST)
  • BioGaia AB (publ) (BIOG-B.ST)
  • Elekta AB (publ) (EKTA-B.ST)
  • Swedencare AB (publ) (SECARE.ST)
  • Synsam AB (publ) (SYNSAM.ST)

Open Bonesupport Holding AB (publ) (BONEX.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.